by Brooke Blazr | Apr 13, 2026 | High Dispatch
Advanced cannabis products give medical patients tools that simply did not exist a decade ago. From terpene-rich live resin to precise tinctures and targeted topicals, the options available today reflect a maturing industry focused on quality and patient...
by Brooke Blazr | Apr 13, 2026 | High Dispatch
Consistent cannabis quality is not a luxury for medical users. It is a fundamental part of getting reliable results. From accurate cannabinoid labeling to clean growing practices and proper storage, every detail in the supply chain contributes to whether a...
by Brooke Blazr | Apr 7, 2026 | High Dispatch
In 2021, Mexico’s Supreme Court declared cannabis prohibition unconstitutional, setting the stage for full legalization. Then Congress proceeded to do absolutely nothing with that ruling for years. The legislative process stalled, got punted, stalled again. So...
by Brooke Blazr | Apr 3, 2026 | High Dispatch
The United States Army just quietly removed one of its longest-standing barriers to enlistment. Recruits with a marijuana-related conviction were previously required to undergo a two-year waiting period, seek a special Pentagon waiver, and pass a drug test. Those...
by Brooke Blazr | Apr 2, 2026 | High Dispatch
The growth medium is typically agar-based — yes, the same substance used in microbiology to grow bacterial cultures — infused with a formulation derived from something called Murashige and Skoog (MS) salts, a nutrient mixture developed in the 1960s that has become...
by Brooke Blazr | Apr 1, 2026 | High Dispatch
So when the Lancet team searched databases for RCTs treating mental disorders with cannabis as the primary treatment, they found a sparse pool — and then concluded the sparse pool means cannabis doesn’t work. That conclusion is circular. You can’t run a...
